Announcements Trials
Browse Landscape

Status

Recruiting 28Completed 18Unknown 16Not yet recruiting 13Terminated 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 17Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 141Neoplasms 132Prostatic Neoplasms 80Carcinoma, Non-Small-Cell Lung 80Lung Neoplasms 67Colorectal Neoplasms 47Carcinoma, Hepatocellular 37Stomach Neoplasms 32Multiple Myeloma 29Brain Neoplasms 28Uterine Cervical Neoplasms 27Pancreatic Neoplasms 26Ovarian Neoplasms 26Melanoma 25Head and Neck Neoplasms 25Rectal Neoplasms 24Colonic Neoplasms 24Urinary Bladder Neoplasms 22Neoplasm Metastasis 21Hematologic Neoplasms 21Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 19Esophageal Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Endometrial Neoplasms 17Recurrence 15Lymphoma 15Liver Neoplasms 15Cardiovascular Diseases 15COVID-19 15

Interventions

trastuzumab deruxtecan 1Trastuzumab 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Neoplasm, Residual × Clear all
NCT06663787 2026-05-13

HER2 CR

Nagoya City University

Active not recruiting
50 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT05479708 2026-04-08

ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

Ruijin Hospital

Active not recruiting
150 enrolled
Tumor-Agnostic

Neoplasm, Residual

NCT05219734 2024-03-12

MARIA

Invitae Corporation

Active not recruiting
400 enrolled
GastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡